Launch Catch-Up — Research Contract Announced October 26, 2026.
Tulane University said it received a $4 million federal contract to develop an experimental treatment intended to provide rapid, temporary protection against multiple infections.
The four-year project, announced October 26, is led by microbiology researchers James McLachlan and Lisa Morici. Funding comes from the Defense Threat Reduction Agency.
The treatment, called T-prop, uses microscopic particles released by bacteria to stimulate the innate immune system, the body's early response to threats. Unlike a conventional vaccine, it is not designed to create lasting memory of one particular pathogen.
Tulane said preliminary work involved animal experiments. The project will examine how quickly protection develops, how long it lasts and whether different doses or delivery methods work against multiple pathogens.
Researchers also need to establish whether immune activation can provide protection without harmful inflammation. The intended next step is generating evidence to support future human trials, rather than offering a treatment already proven safe and effective in people.
Sources Tulane University — October 26 Contract Announcement: https://news.tulane.edu/pr/tulane-receives-4-million-develop-treatment-could-protect-against-multiple-infections-within